Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells

I don't need a 'war' to fight my cancer. I need empowering as a patient

O bituaries routinely inform us that so-and-so has died "after a brave battle against cancer". 
Of course, we will never read that so-and-so has died "after a pathetically feeble battle against cancer".

Dietary Supplements and Cancer Treatment: A Risky Mixture - NCI bulletin

Ginkgo biloba for Preventing Cognitive Decline in Older Adults

Compugen - Press Release Compugen Discovers Drug Target for Treatment of Epithelial Tumors

Compugen - Investors - Press Releases

Wednesday, December 23, 2009 E-health revolution; Island doctors and nurses first in B.C. to have instant access to patients' histories

Also see my short comment

Serum 25-hydroxyvitamin D and the risk of ovarian cancer

Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening

ntraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

Canadian Association of University Surgeons Annual Symposium: continuity of care (from 2007 - hours of service)

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges

Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors

Forty-five women (73%) had ovarian cancer, 10 (16%) had peritoneal cancer, four (6%) had fallopian tube cancers, and three (5%) had uterine papillary serous tumors.

Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients?

Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma

Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas